Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Experimental and Therapeutic Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/etm.2016.3973PMID 26998043PMCID PMC5347983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages

  2015cited by this paper
• The role of reactive oxygen species and metabolism on cancer cells and their microenvironment.

  2014cited by this paper
• Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.

  2014cited by this paper
• Metformin affects macrophages’ phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages

  2014cited by this paper
• Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells.

  2014cited by this paper
• Oxidative Stress as a Mechanism of Added Sugar-Induced Cardiovascular Disease

  2014cited by this paper
• Monocytes: a novel drug delivery system targeting atherosclerosis

  2014cited by this paper
• MnSOD expression in human atherosclerotic plaques: an immunohistochemical and ultrastructural study.

  2013cited by this paper
• Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences.

  2013cited by this paper
• Inherited catalase deficiency: is it benign or a factor in various age related disorders?

  2013cited by this paper
• Metformin and cancer.

  2013cited by this paper
• Quantitative analysis of SOD2, ALDH1A1 and MGST1 messenger ribonucleic acid in anterior lens epithelium of patients with pseudoexfoliation syndrome

  2013cited by this paper
• Impact of Glutathione Peroxidase-1 Deficiency on Macrophage Foam Cell Formation and Proliferation: Implications for Atherogenesis

  2013cited by this paper
• Metformin and cancer.

  2013cited by this paper
• Relationship between catalase haplotype and arterial aging.

  2013cited by this paper
• Innate sensors of pathogen and stress: linking inflammation to obesity.

  2013cited by this paper
• Short-term antihypertensive therapy lowers the C-reactive protein level.

  2012cited by this paper
• Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation.

  2012cited by this paper
• Human atherosclerotic plaque lipid extract impairs the antioxidant defense capacity of monocytes.

  2012cited by this paper
• Gene expression and activity of antioxidant enzymes in the blood cells of workers who were occupationally exposed to lead.

  2012cited by this paper
• The influence of glutathione on redox regulation by antioxidant proteins and apoptosis in macrophages exposed to 2-hydroxyethyl methacrylate (HEMA).

  2012cited by this paper
• Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure.

  2012cited by this paper
• Expression of NADPH oxidase in human pancreatic islets.

  2012cited by this paper
• Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients

  2011cited by this paper
• The role of peroxidases in the pathogenesis of atherosclerosis.

  2011influential reference
• Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases

  2011cited by this paper
• Metformin induces suppression of NAD(P)H oxidase activity in podocytes.

  2010cited by this paper
• Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia

  2010cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Models of reactive oxygen species in cancer.

  2007cited by this paper
• Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.

  2007cited by this paper
• The ROS Production Induced by a Reverse-Electron Flux at Respiratory-Chain Complex 1 is Hampered by Metformin

  2006cited by this paper
• Monocyte Release of Tumor Necrosis Factor-α and Interleukin-1β in Primary Type IIa and IIb Dyslipidemic Patients Treated With Statins or Fibrates

  2005cited by this paper
• High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.

  2001cited by this paper
• EMBOSS: the European Molecular Biology Open Software Suite.

  2000cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper

• Enhanced antiproliferative and anti-inflammatory effects of combined metformin, tadalafil, and tamsulosin in a rat model of testosterone-induced benign prostatic hyperplasia.

  2026cites this paper
• Examining the clinical relevance of metformin as an antioxidant intervention

  2024cites this paper
• Metformin Ameliorates Postoperative Cognitive Dysfunction through Regulation of the AMPK/SIRT1 Pathway.

  2023cites this paper
• Metformin Intervention—A Panacea for Cancer Treatment?

  2022cites this paper
• High throughput screen of small molecules as potential countermeasures to galactic cosmic radiation induced cellular dysfunction.

  2022cites this paper
• Relationship Between Autophagy and Metabolic Syndrome Characteristics in the Pathogenesis of Atherosclerosis

  2021cites this paper
• Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus

  2021cites this paper
• Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?

  2020cites this paper
• Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity

  2019cites this paper
• Activation of AMPK is neuroprotective in the oxidative stress by advanced glycosylation end products in human neural stem cells

  2017cites this paper
• Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data.

  2017cites this paper
• Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro

  2016cites this paper
• Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling

  2016cites this paper